摘要
目的探讨0.1%盐酸奥洛他定滴眼液联合0.1%地塞米松治疗过敏性结膜炎的临床疗效。方法选取2011年12月—2012年12月在我院眼科门诊接受治疗的过敏性结膜炎患者180例,将患者随机分为试验组和对照组,分别给予0.1%盐酸奥洛他定滴眼液+0.1%地塞米松治疗和单纯给予0.1%盐酸奥洛他定滴眼液治疗,1个疗程后,比较两组的临床疗效。结果经秩和检验,试验组的治疗效果等级优于对照组(u=-3.23,P=0.0012)。结论 0.1%盐酸奥洛他定滴眼液联合0.1%地塞米松治疗过敏性结膜炎,与单纯0.1%盐酸奥洛他定滴眼液相比,疗效更确切、安全,值得临床进一步推广。
Objective. To explore the 0. 1% olopatadine hydroehloride ophthalmic solution 0. 1% of the clinical effi- cacy of combined dexamethasone treatment of allergic conjunctivitis. Methods Selection in December 2011 - December 2012 in our hospital ophthalmology clinic treatment, 180 cases of patients with allergic conjunctivitis. 180 patients with allergic con- junctivitis were randomly divided into experimental and control groups, treated with 0. 1% olopatadine and 0. 1% dexamethasone and 0. 1% olopatadine only for a course of treatment, then the clinical efficacy of two groups were compared. Results The therapeutic effect level of the experimental group was better than that of the control group （μ = - 3.23, P = 0. 0012）. Conclu- sion 0. 1% olopatadine combined with 0. 1% dexamethasone for treatment of allergic conjunctivitis is more exact, safety and worthy of further promotion.
出处
《临床合理用药杂志》
2014年第3期26-27,共2页
Chinese Journal of Clinical Rational Drug Use
